SPEC PerkinElmer 11.10
|Webcasts|July 22, 2021

Preclinical Models for Cancer Research and Drug Discovery

Thursday July 22, 2021 at 11am EDT| 8am PDT| 4pm BST|5pm CEST

Register Free: http://www.spectroscopyonline.com/spec_w/cancer

Event Overview:

Cancer remains the primary cause of mortality around the globe, and one significant aspect for the development of efficient anticancer drugs in humans is to better understand human cancer biology during the preclinical stage of drug discovery. Researchers are developing effective preclinical models to investigate tumorigenesis and other significant hallmarks of cancer, including sustaining proliferation, evading growth suppressors, resisting cell death, stimulating angiogenesis, activating invasion and metastasis, etc. In this webinar, we will review the currently available robust preclinical cancer models used by the cancer research community, along with an in-depth review of some genotoxic chemical carcinogens.

Key Learning Objectives:

  • Learning about all existing and emerging preclinical cancer models and their utility in drug discovery and development.
  • Will deep dive into carcinogen induced models highlighting the advantages and limitations of each model
  • Learn how nitrosamines and related N-nitroso compounds are acting as emerging environmental carcinogens

Who Should Attend:

Basic and translational cancer researchers, preclinical pharmacologists, drug discovery researchers, contract research organizations, and knowledge seekers at all levels in the biomedical field.

Speakers

Dr. Sumeet Gullaiya
GTM Manager
Toronto Research Chemicals

Sumeet Gullaiya has completed his PhD (Pharmacology and Toxicology) from Delhi Institute of Pharmaceutical Sciences and Research, India. He has worked as an Assistant Professor in a premier research oriented academic organization. He has published more than 25 papers in reputed journals of national and international repute, authored 3 books, filed 2 patents and is also serving as an Editorial Board Member and Reviewer for reputed journals. Currently, he is working as Product Manager in a leading research chemical manufacturing company, Toronto Research Chemicals (TRC).

Register Free: http://www.spectroscopyonline.com/spec_w/cancer


Related to this article

Monitoring Sugar Consumption and Ethanol Production During Yeast Fermentation Using a Raman Plate Reader and Multivariate Analysis
This column shows that a Raman plate reader paired with partial least squares regression can simultaneously quantify glucose, fructose, sucrose, and ethanol in yeast fermentation samples, using turbidity-matched calibration standards to correct for yeast-induced turbidity, and offers a rapid, label-free, high-throughput method for tracking sugar consumption and ethanol production in strain screening, media optimization, and process development.
Highly Substituted Benzene Rings—The Rest of the Story II: Spectra
This column, the second installment on highly substituted benzene rings, shows that tri- and tetra-substituted substitution patterns can be distinguished by whether the ring bending peak is present and by the position of the in-phase aryl C-H wagging peak, which shifts according to how many adjacent hydrogens the ring carries.
Healthcare administrator reviewing an insurance policy schedule with a stethoscope on a clipboard, health insurance coverage, medical underwriting, prior authorization, and patient claims processing. | Image Credit: Joi_studio - stock.adobe.com
In a SciX interview, Marc Porter covered a lot of ground, from a student-driven pivot into immunoassays to a baseball analogy for Stokes and anti-Stokes scattering, and shares the open questions he is still chasing.
Ingots of pure copper or pink gold on a black background. | Image Credit: Phawat - stock.adobe.com
At SciX, Kevin Wilkinson of the Universite de Montreal explains how faster data acquisition and new software have cut analysis time and how a particle’s chemical composition can link arsenic-bearing emissions back to a copper refinery’s processes.
Spectral Frontiers: Seeing the Unseeable Microspectroscopy
Microspectroscopy, the marriage of spectroscopic chemical identification with microscopic spatial resolution, has advanced from Perkin-Elmer's first commercial infrared microspectrometer in 1953 to today's nanoscale AFM-IR probes, synchrotron-brightness infrared beamlines, and compact hyperspectral tissue imaging devices being developed for AI-assisted cancer detection.